Compounds > cabazitaxel

cabazitaxel and Penile-Neoplasms

cabazitaxel has been researched along with Penile-Neoplasms* in 2 studies

Trials

1 trial(s) available for cabazitaxel and Penile-Neoplasms

ArticleYear
A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.
    The Journal of international medical research, 2019, Volume: 47, Issue:10

    Topics: Adult; Aged; Humans; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Quality of Life; Recurrence; Taxoids; Treatment Outcome

2019

Other Studies

1 other study(ies) available for cabazitaxel and Penile-Neoplasms

ArticleYear
Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report.
    Urology journal, 2017, Jan-18, Volume: 14, Issue:1

    Penile metastases are extremely rare events and generally occurs at a late stage of primary disease. They mostlyoriginate from prostate and bladder in the genitourinary tract. Penile metastases have a dismal prognosis and verylow survival rates. We report a case of penile metastasis in 70-year-old geriatric male patient with prostatic adenocarcinomawho was treated with cabazitaxel chemotherapy beyond 20 cycles with a good response and acceptableminimal toxicity.

    Topics: Adenocarcinoma; Aged; Humans; Male; Penile Neoplasms; Prostatic Neoplasms; Remission Induction; Taxoids

2017